Logo image of ALFEN.AS

ALFEN N.V. (ALFEN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:ALFEN - NL0012817175 - Common Stock

10.57 EUR
-0.33 (-3.03%)
Last: 1/8/2026, 5:29:25 PM
Fundamental Rating

4

Overall ALFEN gets a fundamental rating of 4 out of 10. We evaluated ALFEN against 70 industry peers in the Electrical Equipment industry. The financial health of ALFEN is average, but there are quite some concerns on its profitability. ALFEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALFEN had negative earnings in the past year.
In the past year ALFEN had a positive cash flow from operations.
ALFEN had positive earnings in 4 of the past 5 years.
In the past 5 years ALFEN always reported a positive cash flow from operatings.
ALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

ALFEN has a worse Return On Assets (-5.10%) than 68.57% of its industry peers.
The Return On Equity of ALFEN (-11.46%) is worse than 68.57% of its industry peers.
Industry RankSector Rank
ROA -5.1%
ROE -11.46%
ROIC N/A
ROA(3y)5.55%
ROA(5y)7.18%
ROE(3y)11.38%
ROE(5y)14.51%
ROIC(3y)N/A
ROIC(5y)N/A
ALFEN.AS Yearly ROA, ROE, ROICALFEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Gross Margin of ALFEN (34.60%) is comparable to the rest of the industry.
ALFEN's Gross Margin has declined in the last couple of years.
ALFEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
ALFEN.AS Yearly Profit, Operating, Gross MarginsALFEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

ALFEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALFEN remains at a similar level compared to 1 year ago.
ALFEN has more shares outstanding than it did 5 years ago.
ALFEN has a better debt/assets ratio than last year.
ALFEN.AS Yearly Shares OutstandingALFEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALFEN.AS Yearly Total Debt VS Total AssetsALFEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALFEN has an Altman-Z score of 2.69. This is not the best score and indicates that ALFEN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ALFEN (2.69) is better than 64.29% of its industry peers.
ALFEN has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.98, ALFEN belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
ALFEN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, ALFEN is in the better half of the industry, outperforming 67.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.98
Altman-Z 2.69
ROIC/WACCN/A
WACC7.97%
ALFEN.AS Yearly LT Debt VS Equity VS FCFALFEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALFEN has a Current Ratio of 1.75. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
ALFEN has a better Current ratio (1.75) than 65.71% of its industry peers.
ALFEN has a Quick Ratio of 1.08. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.08, ALFEN is doing good in the industry, outperforming 67.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.08
ALFEN.AS Yearly Current Assets VS Current LiabilitesALFEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for ALFEN have decreased strongly by -286.94% in the last year.
The Revenue for ALFEN has decreased by -13.84% in the past year. This is quite bad
ALFEN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.79% yearly.
EPS 1Y (TTM)-286.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.22%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%

3.2 Future

ALFEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.45% yearly.
ALFEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y184.95%
EPS Next 2Y85.66%
EPS Next 3Y60.79%
EPS Next 5Y48.45%
Revenue Next Year-9.49%
Revenue Next 2Y-2.72%
Revenue Next 3Y0.44%
Revenue Next 5Y3.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALFEN.AS Yearly Revenue VS EstimatesALFEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ALFEN.AS Yearly EPS VS EstimatesALFEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

ALFEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 45.75 indicates a quite expensive valuation of ALFEN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALFEN indicates a slightly more expensive valuation: ALFEN is more expensive than 70.00% of the companies listed in the same industry.
ALFEN is valuated expensively when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 45.75
ALFEN.AS Price Earnings VS Forward Price EarningsALFEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

ALFEN's Enterprise Value to EBITDA ratio is in line with the industry average.
94.29% of the companies in the same industry are more expensive than ALFEN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.59
EV/EBITDA 29.1
ALFEN.AS Per share dataALFEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ALFEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALFEN's earnings are expected to grow with 60.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.66%
EPS Next 3Y60.79%

0

5. Dividend

5.1 Amount

ALFEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALFEN N.V.

AMS:ALFEN (1/8/2026, 5:29:25 PM)

10.57

-0.33 (-3.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-04 2025-11-04
Earnings (Next)02-10 2026-02-10/amc
Inst Owners47.73%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap229.90M
Revenue(TTM)453.43M
Net Income(TTM)-17.30M
Analysts44.71
Price Target10.11 (-4.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.91%
PT rev (3m)-5.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3854.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.75
P/S 0.51
P/FCF 4.59
P/OCF 3.51
P/B 1.51
P/tB 1.88
EV/EBITDA 29.1
EPS(TTM)-0.79
EYN/A
EPS(NY)0.23
Fwd EY2.19%
FCF(TTM)2.3
FCFY21.79%
OCF(TTM)3.01
OCFY28.46%
SpS20.85
BVpS6.99
TBVpS5.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.1%
ROE -11.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.6%
FCFM 11.05%
ROA(3y)5.55%
ROA(5y)7.18%
ROE(3y)11.38%
ROE(5y)14.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.98
Debt/EBITDA 4.33
Cap/Depr 57.04%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion 708.01%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.08
Altman-Z 2.69
F-Score5
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)184.38%
Cap/Depr(5y)167.71%
Cap/Sales(3y)5.61%
Cap/Sales(5y)5.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-286.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.22%
EPS Next Y184.95%
EPS Next 2Y85.66%
EPS Next 3Y60.79%
EPS Next 5Y48.45%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%
Revenue Next Year-9.49%
Revenue Next 2Y-2.72%
Revenue Next 3Y0.44%
Revenue Next 5Y3.16%
EBIT growth 1Y-209.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year713.65%
EBIT Next 3Y116.35%
EBIT Next 5Y70.87%
FCF growth 1Y165.52%
FCF growth 3YN/A
FCF growth 5Y33.16%
OCF growth 1Y243.72%
OCF growth 3Y74.51%
OCF growth 5Y31.77%

ALFEN N.V. / ALFEN.AS FAQ

What is the ChartMill fundamental rating of ALFEN N.V. (ALFEN.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALFEN.AS.


Can you provide the valuation status for ALFEN N.V.?

ChartMill assigns a valuation rating of 4 / 10 to ALFEN N.V. (ALFEN.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for ALFEN N.V.?

ALFEN N.V. (ALFEN.AS) has a profitability rating of 2 / 10.


How financially healthy is ALFEN N.V.?

The financial health rating of ALFEN N.V. (ALFEN.AS) is 6 / 10.


What is the expected EPS growth for ALFEN N.V. (ALFEN.AS) stock?

The Earnings per Share (EPS) of ALFEN N.V. (ALFEN.AS) is expected to grow by 184.95% in the next year.